Status:
COMPLETED
TXI for the Recognition of Adenomas in Colonoscopy
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Colorectal Polyp
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
This two parallel arms, randomized, multicenter trial is aimed at evaluating whether TXI is superior to WLI endoscopy in terms of adenoma detection. Secondary aims will be advanced adenoma detection r...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- All \>40 years-old patients undergoing a colonoscopy for primary screening, Faecal Immunochemical Test (FIT) +, post-polypectomy surveillance
- Exclusion criteria:
- patients with personal history of colorectal cancer (CRC), or Inflammatory Bowel Disease (IBD).
- Patients affected with Lynch syndrome or Familiar Adenomatous Polyposis.
- patients with inadequate bowel preparation (defined as Boston Bowel Preparation Scale \<2 in any colonic segment).
- patients with previous colonic resection.
- patients on antithrombotic therapy, precluding polyp resection.
- patients who were not able or refused to give informed written consent.
Exclusion
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
747 Patients enrolled
Trial Details
Trial ID
NCT04892966
Start Date
April 1 2021
End Date
September 30 2022
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Dei Castelli
Ariccia, Rome, Italy, 00040